Anadolu Medical Center
The cost of kidney cancer treatment in Turkey varies depending on the specific procedures and medical needs of the patient. Initial diagnostics, including consultations with medical oncologists and radiologists, range from $200 to $1,300. For surgical interventions, a laparoscopic radical nephrectomy can cost around $11,000, while a more advanced robotic surgery might reach up to $24,000. Additionally, a kidney transplant procedure is estimated at $19,000, inclusive of all necessary medical assessments and hospital stay. The overall treatment plan is tailored based on the patient"s condition and the detailed evaluation by the medical team.
| Turcja | Austria | Hiszpania | |
| Usunięcie nerki | od $10,000 | od $22,000 | od $15,000 |
| Terapia protonowa | od $70,000 | od $80,000 | od $25,900 |
| System da Vinci do chirurgii robotycznej | od $9,500 | od $22,000 | od $17,000 |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
| Nefrektomia z użyciem robota Da Vinci | od $10,000 | od $16,000 | od $20,000 |
Prof. dr Bülent Karagöz specjalizuje się w biologii nowotworów oraz immunoterapii. Posiada ponad 20-letnie doświadczenie i zajmuje się leczeniem raka nerki w Anadolu Medical Center.
Zajmuje 3. miejsce w Turcji w dziedzinie onkologii — dr Tanrikulu wnosi specjalistyczną wiedzę w zakresie leczenia raka nerki w Centrum Medycznym Anadolu.
Dr Solak przeszedł specjalistyczne szkolenie w Instytucie Onkologii Uniwersytetu Hacettepe i posiada bogate doświadczenie w leczeniu różnych nowotworów, w tym przypadków raka nerki w Hisar Hospital Intercontinental.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.